Jasper Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q2 2023 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Jasper Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q2 2023 to Q3 2023.
  • Jasper Therapeutics, Inc. Marketable Securities, Current for the quarter ending September 30, 2023 was $3.4M.
Marketable Securities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.4M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.2M Jun 30, 2023 10-Q 2023-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.